Should I buy or sell SeaStar Medical stock right now?

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SeaStar Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU shares. View ICU analyst ratings or view top-rated stocks .

What is SeaStar Medical's stock price target for 2024?

1 equities research analysts have issued 12 month price objectives for SeaStar Medical's stock. Their ICU share price targets range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 792.9% from the stock's current price. View analysts price targets for ICU or view top-rated stocks among Wall Street analysts .

How have ICU shares performed in 2023?

SeaStar Medical's stock was trading at $4.10 at the start of the year. Since then, ICU stock has decreased by 86.3% and is now trading at $0.56. View the best growth stocks for 2023 here .

Are investors shorting SeaStar Medical?

SeaStar Medical saw a drop in short interest in November. As of November 15th, there was short interest totaling 526,700 shares, a drop of 81.5% from the October 31st total of 2,850,000 shares. Based on an average daily trading volume, of 16,100,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 3.9% of the shares of the stock are sold short. View SeaStar Medical's Short Interest .

When is SeaStar Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024. View our ICU earnings forecast .

How were SeaStar Medical's earnings last quarter?

SeaStar Medical Holding Co. (NASDAQ:ICU) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.12) EPS for the quarter.

Who are SeaStar Medical's major shareholders?

SeaStar Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Shaolin Capital Management LLC (0.00%). Insiders that own company stock include Heel Kenneth Van, Kevin Chung and Richard D Russell. View institutional ownership trends .

How do I buy shares of SeaStar Medical?

Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

SeaStar Medical Stock Price, News & Analysis (NASDAQ:ICU)

$0.56

+0.08 (+16.67%)

(As of 12/8/2023 ET)

Compare

Today's Range: $0.47
▼
$0.59
50-Day Range: $0.37
▼
$1.19
52-Week Range: $0.16
▼
$6.34

Volume: 4.17 million shs
Average Volume: 4.83 million shs
Market Capitalization: $23.59 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $5.00

SeaStar Medical MarketRank™ Stock Analysis

Analyst Rating: Buy
3.00 Rating Score
Upside/Downside: 792.9% Upside
$5.00 Price Target
Short Interest: Healthy
3.88% of Float Sold Short
Dividend Strength: N/A
Sustainability: N/A
News Sentiment: N/A
Insider Trading: Acquiring Shares
$40,000 Bought Last Quarter
Proj. Earnings Growth: N/A

Overall MarketRank^™

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.45 out of 5 stars

Medical Sector

158th out of 954 stocks

Surgical & Medical Instruments Industry

17th out of 70 stocks

3.5

Analyst's Opinion

Consensus Rating
SeaStar Medical has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 1 buy rating, no hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $5.00, SeaStar Medical has a forecasted upside of 792.9% from its current price of $0.56.
Amount of Analyst Coverage
SeaStar Medical has received no research coverage in the past 90 days.

5.0

Short Interest

Percentage of Shares Shorted
3.88% of the float of SeaStar Medical has been sold short.
Short Interest Ratio / Days to Cover
SeaStar Medical has a short interest ratio ("days to cover") of 0, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month
Short interest in SeaStar Medical has recently decreased by 81.52%, indicating that investor sentiment is improving significantly.

0.0

Dividend Strength

Dividend Yield
SeaStar Medical does not currently pay a dividend.
Dividend Growth
SeaStar Medical does not have a long track record of dividend growth.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for ICU.

0.0

News and Social Media Coverage

Search Interest
Only 6 people have searched for ICU on MarketBeat in the last 30 days. This is a decrease of -86% compared to the previous 30 days.
MarketBeat Follows
Only 4 people have added SeaStar Medical to their MarketBeat watchlist in the last 30 days. This is a decrease of -20% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, SeaStar Medical insiders have bought more of their company's stock than they have sold. Specifically, they have bought $40,000.00 in company stock and sold $0.00 in company stock.
Percentage Held by Insiders
Only 4.50% of the stock of SeaStar Medical is held by insiders.
Percentage Held by Institutions
Only 11.63% of the stock of SeaStar Medical is held by institutions.

N/A

Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

About SeaStar Medical Stock (NASDAQ:ICU)

SeaStar Medical Holding Corporation, a medical device company, develops a platform therapy to reduce the consequences of hyperinflammation on vital organs in the United States. The company offers inflammatory response to fend off infections and repair damaged tissue in the body. It is also developing products in various therapeutic areas, including pediatric and adult acute kidney injury on CRRT; cardiorenal syndrome in congestive heart failure; myocardial stunning in end stage renal disease; and hepatorenal syndrome. SeaStar Medical Holding Corporation is headquartered in Denver, Colorado.

ICU Stock Price History

30 days | 90 days | 365 days | Advanced Chart

ICU Stock News Headlines

November 23, 2023 | markets.businessinsider.com

Promising Clinical Trials and Strong Financial Positioning Bolster Buy Rating Recommendation for SeaStar Medical Holdings

November 14, 2023 | finance.yahoo.com

SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update

December 9, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

All the trading advice you’ve ever received boils down to one goal and one goal only: finding a reliable edge in the markets. If you can do that, grab hold of it and never let go. Because once you have that edge, and you can count on it, you never need to do anything else.

November 1, 2023 | markets.businessinsider.com

Analysts Offer Insights on Healthcare Companies: Reviva Pharmaceuticals Holdings (RVPH) and SeaStar Medical Holding (ICU)

October 30, 2023 | marketwatch.com

SeaStar Medical Shares Rise 13% After FDA Approvable Letter

October 30, 2023 | msn.com

SeaStar Medical gets Approvable Letter for SCD-PED device

October 30, 2023 | finance.yahoo.com

FDA Issues Approvable Letter for SeaStar Medical’s Selective Cytopheretic Device for Pediatric Patients

October 27, 2023 | benzinga.com

Why SeaStar Medical Holding Company Stock Is Soaring

December 9, 2023 | DTI Trader (Ad)

All the trading advice you’ve ever received boils down to this

October 27, 2023 | msn.com

SeaStar Medical rises 28%, withdraws equity offering

October 19, 2023 | msn.com

What's Going On With Medical Devices Focused SeaStar Medical Stock Today?

October 18, 2023 | marketwatch.com

SeaStar Medical Shares Surge 52% on FDA Breakthrough Designation

October 18, 2023 | finance.yahoo.com

FDA Grants SeaStar Medical’s Selective Cytopheretic Device Breakthrough Device Designation for Hepatorenal Syndrome

October 5, 2023 | finance.yahoo.com

SeaStar Medical to Present at the Dawson James Small Cap Growth Conference on October 12, 2023

October 3, 2023 | finance.yahoo.com

SeaStar Medical Provides Regulatory Update Regarding Selective Cytopheretic Device Use in Pediatric Acute Kidney Injury Under a Humanitarian Device Exemption

September 29, 2023 | marketwatch.com

SeaStar Medical Shares Rise 36% After Breakthrough Device Designation for Selective Cytopheretic Device

September 29, 2023 | baystreet.ca

SeaStar Sails on FDA Nod

September 29, 2023 | markets.businessinsider.com

SeaStar Medical Reports Breakthrough Device Designation For Selective Cytopheretic Device

September 29, 2023 | finance.yahoo.com

FDA Grants Breakthrough Device Designation to SeaStar Medical’s Selective Cytopheretic Device for Cardiorenal Syndrome

August 29, 2023 | finance.yahoo.com

Case Series of Three Critically Ill Children with Acute Kidney Injury Safely Treated with SeaStar Medical’s Selective Cytopheretic Device Published in the Journal Blood Purification

August 22, 2023 | finance.yahoo.com

SeaStar Medical to Hold Business Update Conference Call Today at 4:00 p.m. Eastern Time

August 15, 2023 | finanznachrichten.de

SeaStar Medical Holding Corporation: SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update

August 14, 2023 | finance.yahoo.com

SeaStar Medical Reports Second Quarter 2023 Financial Results and Provides a Business Update

June 30, 2023 | finance.yahoo.com

SeaStar Medical to Sponsor the Critical Care Time Podcast Series Covering Vital Medical Issues for Healthcare Professionals Who Care for Critically Ill Patients

June 20, 2023 | finance.yahoo.com

First Patient Enrolled in SeaStar Medical’s Pivotal Clinical Trial with the Selective Cytopheretic Device in Adults with Acute Kidney Injury

June 14, 2023 | finance.yahoo.com

SeaStar Medical to Present at the Maxim Group Virtual Healthcare Conference Hosted by M-Vest on June 21, 2023

May 17, 2023 | finanznachrichten.de

SEASTAR MEDICAL HOLDING CORPORATION

See More Headlines

Receive ICU Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for SeaStar Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 11/14/2023
Today: 12/09/2023
Fiscal Year End: 12/31/2023
Next Earnings (Estimated): 4/04/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Surgical & medical instruments
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:ICU
CUSIP: N/A
CIK: 1831868
Web: seastarmedical.com
Phone: 844-427-8100
Fax: N/A
Employees: 9
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $5.00
High Stock Price Target: $5.00
Low Stock Price Target: $5.00
Potential Upside/Downside: +792.9%
Consensus Rating: Buy
Rating Score (0-4): 3.00
Research Coverage: 1 Analysts

Profitability

EPS (Most Recent Fiscal Year): N/A
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-23,010,000.00
Net Margins: N/A
Pretax Margin: N/A
Return on Equity: N/A
Return on Assets: -961.93%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.18
Quick Ratio: 0.18

Sales & Book Value

Annual Sales: N/A
Price / Sales: N/A
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.64) per share
Price / Book: -0.88

Miscellaneous

Outstanding Shares: 42,122,000
Free Float: 35,316,000
Market Cap: $23.59 million
Optionable: Not Optionable
Beta: -1.22

10 "Recession Proof" Stocks That Will Thrive in Any Market

Which stocks are likely to thrive in today's challenging market? Click the link below and we'll send you MarketBeat's list of ten stocks that will drive in any economic environment.

Get This Free Report

Key Executives

Mr. Eric Schlorff (Age 50)
CEO, President & Executive Director
Comp: $690k
Dr. H. David Humes M.D.
Co-Founder and Managing Director
Ms. Caryl Baron (Age 56)
Interim Chief Financial Officer
Comp: $225k
Colonel Kevin Chung FACP (Age 50)
M.D., Chief Medical Officer
Comp: $375k
Tom Mullen
Vice President of Operations & Product Development

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

ICU Stock Analysis - Frequently Asked Questions

Should I buy or sell SeaStar Medical stock right now?: 1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for SeaStar Medical in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" ICU shares.
View ICU analyst ratings or view top-rated stocks.
What is SeaStar Medical's stock price target for 2024?: 1 equities research analysts have issued 12 month price objectives for SeaStar Medical's stock. Their ICU share price targets range from $5.00 to $5.00. On average, they anticipate the company's stock price to reach $5.00 in the next year. This suggests a possible upside of 792.9% from the stock's current price.
View analysts price targets for ICU or view top-rated stocks among Wall Street analysts.
How have ICU shares performed in 2023?: SeaStar Medical's stock was trading at $4.10 at the start of the year. Since then, ICU stock has decreased by 86.3% and is now trading at $0.56.
View the best growth stocks for 2023 here.
Are investors shorting SeaStar Medical?: SeaStar Medical saw a drop in short interest in November. As of November 15th, there was short interest totaling 526,700 shares, a drop of 81.5% from the October 31st total of 2,850,000 shares. Based on an average daily trading volume, of 16,100,000 shares, the days-to-cover ratio is currently 0.0 days. Currently, 3.9% of the shares of the stock are sold short.
View SeaStar Medical's Short Interest.

When is SeaStar Medical's next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 4th 2024.
View our ICU earnings forecast.
How were SeaStar Medical's earnings last quarter?: SeaStar Medical Holding Co. (NASDAQ:ICU) released its quarterly earnings data on Tuesday, November, 14th. The company reported ($0.12) EPS for the quarter.
Who are SeaStar Medical's major shareholders?: SeaStar Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Shaolin Capital Management LLC (0.00%). Insiders that own company stock include Heel Kenneth Van, Kevin Chung and Richard D Russell.
View institutional ownership trends.
How do I buy shares of SeaStar Medical?: Shares of ICU stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:ICU) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial